UA104000C2 - Glucagon/glp-1 receptor co-agonists for the treatment of metabolic disorder and obesity - Google Patents

Glucagon/glp-1 receptor co-agonists for the treatment of metabolic disorder and obesity

Info

Publication number
UA104000C2
UA104000C2 UAA201015130A UAA201015130A UA104000C2 UA 104000 C2 UA104000 C2 UA 104000C2 UA A201015130 A UAA201015130 A UA A201015130A UA A201015130 A UAA201015130 A UA A201015130A UA 104000 C2 UA104000 C2 UA 104000C2
Authority
UA
Ukraine
Prior art keywords
glucagon
glp
obesity
agonists
receptor
Prior art date
Application number
UAA201015130A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Річард Денніс Дімарчі
Ма Тао
Original Assignee
Индиана Юниверсити Рисьорч Энд Текнолоджи Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Индиана Юниверсити Рисьорч Энд Текнолоджи Корпорейшн filed Critical Индиана Юниверсити Рисьорч Энд Текнолоджи Корпорейшн
Priority claimed from PCT/US2009/047447 external-priority patent/WO2010011439A2/en
Publication of UA104000C2 publication Critical patent/UA104000C2/en

Links

Abstract

Glucagon peptides that exhibit GIP agonist activity in addition to glucagon and/or GLP-I activity are provided. Pharmaceutical compositions comprising such glucagon peptides and therapeutic methods of using such peptides are also provided.
UAA201015130A 2008-06-17 2009-06-16 Glucagon/glp-1 receptor co-agonists for the treatment of metabolic disorder and obesity UA104000C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7327408P 2008-06-17 2008-06-17
PCT/US2009/047447 WO2010011439A2 (en) 2008-06-17 2009-06-16 Gip-based mixed agonists for treatment of metabolic disorders and obesity

Publications (1)

Publication Number Publication Date
UA104000C2 true UA104000C2 (en) 2013-12-25

Family

ID=52285771

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201015130A UA104000C2 (en) 2008-06-17 2009-06-16 Glucagon/glp-1 receptor co-agonists for the treatment of metabolic disorder and obesity

Country Status (1)

Country Link
UA (1) UA104000C2 (en)

Similar Documents

Publication Publication Date Title
EA020326B9 (en) Gip-based mixed agonists for treatment of metabolic disorders and obesity
PH12017500761A1 (en) Co-agonists of glucagon and glp-1 receptors
NZ612297A (en) Glucagon analogs exhibiting gip receptor activity
MX366325B (en) Combination therapy.
ZA200807789B (en) Neuromedin U receptor agonists and uses thereof
PH12016500675B1 (en) Acylated glucagon analogues
MX2012008603A (en) Glucagon antagonist - gip agonist conjugates and compositions for the treatment of metabolic disorders and obesity.
MX2015003293A (en) Glucagon analogues.
GEP20176629B (en) Glucagon/glp-1 receptor co-agonists
EA035466B9 (en) Gip-glp-1 dual agonist compounds and methods
GB2465677B (en) Non-systemic delivery of satiogens for use in the treatment of obesity and/or diabetes
IL207532A0 (en) Glp-1 receptor agonists and related phamaceutical ingredients for the treatment of cancer
HK1220631A1 (en) Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
CL2012000702A1 (en) Use of an alpha-7 nicotinic acetylcholine receptor agonist for the treatment of dyskinesia associated with dopamine agonist therapy in Parkinson's disease.
MY188182A (en) Acylated glucagon analogues
TN2012000216A1 (en) Pharmaceutical composition comprising a glp-1 agonist, an insulin, and methionine
MX2018010640A (en) Glucagon and glp-1 co-agonists for the treatment of obesity.
MX2013007622A (en) A combination of an opioid agonist and an opioid antagonist in the treatment of parkinson's disease.
EP2322175A4 (en) Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof
TW201129573A (en) Pyrimidine ether derivatives and methods of use thereof
UA104000C2 (en) Glucagon/glp-1 receptor co-agonists for the treatment of metabolic disorder and obesity
EP2464355A4 (en) Substituted triazolophthalazine derivatives
UA106478C2 (en) Combination of insulin and glp-1 agonist
UA114792C2 (en) Glucagpn/glp-1 receptor co-agonists
TN2011000667A1 (en) Acylated glucagon analogues